Pharma Journalist -

SMi Reports: It is with great pleasure and delight that we have AstraZeneca presenting at this year’s RNA Therapeutics virtual conference. Join us in February 2021, as SMi’s 12th…
Read More...

SMi Reports: SMi Group are delighted to announce that Dr Eric Noehrenberg, President, NIPC will be a speaker at the Parallel Trade virtual conference taking place in March 2021. SMi…
Read More...

SMi Reports: The agenda and speaker line-up for the upcoming Pharmaceutical Microbiology East Coast Conference, which will convene as a virtual conference on April 28th and 29th, 2021…
Read More...

Pfizer Inc. and Sangamo Therapeutics, Inc. a genomic medicines company, today announced updated follow-up data from the Phase 1/2 Alta study of giroctocogene fitelparvovec (SB-525 or…
Read More...

Passage Bio, Inc. a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system (CNS) disorders, and Catalent, the leading global…
Read More...

PostEra, a biotechnology company specializing in machine learning solutions for preclinical drug discovery,  announced a strategic partnership with Pfizer Inc. with the goal of…
Read More...

Cybin Inc. announced the signing of a definitive agreement to acquire 100% of the shares in Adelia Therapeutics Inc. for up to CDN$20,161,575 (approximately USD$15.75 million) in an…
Read More...

Aligos Therapeutics, Inc. announced that it has entered into an Exclusive License and Research Collaboration Agreement with Merck, known as MSD outside the United States and Canada,…
Read More...

Syros Pharmaceuticals, a leader in the development of medicines that control the expression of genes, announced that it has acquired from Orsenix, LLC (Orsenix) all of its assets…
Read More...

SMi Reports: SMi Group are delighted to announce that Séverine Duband, Global Category Manager, Nemera will be a speaker at the Pre-filled Syringes Europe Conference SMi Group is…
Read More...